Antifungal and antibiofilm effects of probiotic Lactobacillus salivarius, zinc nanoparticles, and zinc nanocomposites against Candida albicans from Nile tilapia (Oreochromis niloticus), water and humans

dc.AffiliationOctober University for modern sciences and Arts MSA
dc.contributor.authorEl-Gazzar, Nashwa
dc.contributor.authorAbou Elez, Rasha M. M
dc.contributor.authorAttia, Amira S. A
dc.contributor.authorAbdel-Warith, Abdel-Wahab A
dc.contributor.authorDarwish, Manal M
dc.contributor.authorYounis, Elsayed M
dc.contributor.authorEltahlawi, Rehab A
dc.contributor.authorMohamed, Kawthar Ibraheem
dc.contributor.authorDavies, Simon J
dc.contributor.authorElsohaby, Ibrahim
dc.date.accessioned2024-06-23T10:45:26Z
dc.date.available2024-06-23T10:45:26Z
dc.date.issued2024-06
dc.description.abstractIntroduction: Candida albicans (C. albicans) can form biofilms; a critical virulence factor that provides effective protection from commercial antifungals and contributes to public health issues. The development of new antifungal therapies, particularly those targeting biofilms, is imperative. Thus, this study was conducted to investigate the antifungal and antibiofilm effects of Lactobacillus salivarius (L. salivarius), zinc nanoparticles (ZnNPs) and nanocomposites (ZnNCs) on C. albicans isolates from Nile tilapia, fish wash water and human fish sellers in Sharkia Governorate, Egypt. Methods: A cross-sectional study collected 300 samples from tilapia, fish wash water, and fish sellers (100 each). Probiotic L. salivarius was immobilized with ZnNPs to synthesize ZnNCs. The study assessed the antifungal and antibiofilm activities of ZnNPs, L. salivarius, and ZnNCs compared to amphotericin (AMB). Results: Candida spp. were detected in 38 samples, which included C. albicans (42.1%), C. glabrata (26.3%), C. krusei (21.1%), and C. parapsilosis (10.5%). A total of 62.5% of the isolates were resistant to at least one antifungal agent, with the highest resistance to nystatin (62.5%). However, 75% of the isolates were highly susceptible to AMB. All C. albicans isolates exhibited biofilm-forming capabilities, with 4 (25%) isolates showing strong biofilm formation. At least one virulence-associated gene (RAS1, HWP1, ALS3, or SAP4) was identified among the C. albicans isolates. Probiotics L. salivarius, ZnNPs, and ZnNCs displayed antibiofilm and antifungal effects against C. albicans, with ZnNCs showing significantly higher inhibitory activity. ZnNCs, with a minimum inhibitory concentration (MIC) of 10 µg/mL, completely reduced C. albicans biofilm gene expression. Additionally, scanning electron microscopy images of C. albicans biofilms treated with ZnNCs revealed asymmetric, wrinkled surfaces, cell deformations, and reduced cell numbers. Conclusion: This study identified virulent, resistant C. albicans isolates with strong biofilm-forming abilities in tilapia, water, and humans, that pose significant risks to public health and food safety. Copyright .en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=21100255109&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.3389/fcimb.2024.1358270
dc.identifier.otherhttps://doi.org/10.3389/fcimb.2024.1358270
dc.identifier.urihttp://repository.msa.edu.eg/xmlui/handle/123456789/6072
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.relation.ispartofseriesFrontiers in Cellular and Infection Microbiology;
dc.relation.ispartofseries;Volume 142024 Article number 1358270
dc.subjectantibiofilm activity; Candida albicans; nanocomposite; probiotic; virulence genes; zinc nanoparticlesen_US
dc.titleAntifungal and antibiofilm effects of probiotic Lactobacillus salivarius, zinc nanoparticles, and zinc nanocomposites against Candida albicans from Nile tilapia (Oreochromis niloticus), water and humansen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fcimb-14-1358270.pdf
Size:
3.65 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: